Sebastian Gensior

Sebastian Gensior

Blending technical expertise with big-picture vision. Innovation in AI, biotech, and VC, Running Capital for Cures. Connect: https://www.linkedin.com/in/sgensior/

Super-Responders and Extreme Value Theory (EVT): Unlocking Opportunities in Pharma and Biotech

In drug development, most narratives hinge on averages—median survival times, mean biomarker expression, or standard response rates. Yet, breakthroughs often emerge from outliers, the rare patients who exhibit extraordinary therapeutic benefits. These individuals, known as super-responders, defy conventional expectations, revealing critical insights about a treatment’s potential and underlying
4 min read

Subscribe to P05.org

Don’t miss out on the latest issues. Sign up now to get access to the library of members-only issues.
jamie@example.com
Subscribe